Digital Inhaler With Built-In Sensors Wins FDA Approval

For patients with chronic obstructive pulmonary disease (COPD) or asthma, tracking use of inhalers that deliver vital medications can be a challenge. A recently approved device may help ensure that treatment is administered correctly.

In late December 2018, the Food and Drug Administration (FDA) approved a new digital inhaler from Teva Pharmaceuticals designed to help ensure individuals take their medications correctly. The inhaler features sensors that connect to a smartphone app, then record data that can be shared with clinicians who can assess a patient’s inhaler use.

appreciate 70 to 90 percent of patients make mistakes with their inhalers and don’t get enough medication into their lungs, while other patients may overuse the devices, according to the A study published in July 2016 in the journal Respiratory medicine.

While This type of sensor is not newThe ProAir Digihaler is the first digital inhaler with built-in sensors that detect when the inhaler is used and spirometry.

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button